Cases & Deals

  • Home
  • Practices
  • Axion BioSystems issues Common Stock in Regulation D Rule 506 offering

Share

Axion BioSystems issues Common Stock in Regulation D Rule 506 offering

April 2012

Client(s) Axion Biosystems, Inc.

Jones Day represented Axion BioSystems, Inc., a privately held bio-tech start up company, in connection with its issuance of $3.2 million of Common Stock in a Regulation D Rule 506 offering.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.